Purdue Pharma to stop marketing OxyContin to doctors
Purdue Pharma, maker of prescription pain pill OxyContin, will no longer promote their products to doctors, the company told employees according to several news outlets .
OxyContin is an opioid pain reliever that contains oxycodone, which was the top drug that contributed to fatal overdoses in Westmoreland County in 2009, 2010 and 2011, according to a Tribune-Review report in December.
The move comes as numerous lawsuits have been filed against Purdue Pharma and other drug makers across the country, including in Westmoreland County , as a result of a nationwide drug epidemic. The company's practices are under investigation by Pennsylvania's attorney general. Purdue Pharma told Bloomberg and other news agencies in a statement that it would “no longer be promoting opioids to prescribers,” the outlet reported. OxyContin sales generated $1.8 billion last year, according to Symphony Health Solutions data.Prescriptions of all opioids have decreased in Allegheny and Westmoreland counties over the last year, according to a report from the Tribune-Review based on data from the state Department of Health. Renatta Signorini is a Tribune-Review staff writer. Reach her at 724-837-5374, firstname.lastname@example.org or via Twitter @byrenatta.